189 related articles for article (PubMed ID: 2917591)
1. Effect of diltiazem on the pharmacokinetics of propranolol, metoprolol and atenolol.
Tateishi T; Nakashima H; Shitou T; Kumagai Y; Ohashi K; Hosoda S; Ebihara A
Eur J Clin Pharmacol; 1989; 36(1):67-70. PubMed ID: 2917591
[TBL] [Abstract][Full Text] [Related]
2. Effect of aging on the pharmcokinetics of atenolol, metoprolol and propranolol in the rat.
Belpaire FM; de Smet F; Vynckier LJ; Vermeulen AM; Rosseel MT; Bogaert MG; Chauvelot-Moachon L
J Pharmacol Exp Ther; 1990 Jul; 254(1):116-22. PubMed ID: 2366179
[TBL] [Abstract][Full Text] [Related]
3. Beta-adrenoceptor blockade and CNS-related subjective symptoms: a randomized, double-blind, placebo-controlled comparison of metoprolol CR/ZOK, atenolol and propranolol LA in healthy subjects.
Dimenäs E; Kerr D; Macdonald I
J Clin Pharmacol; 1990 Feb; 30(S2):S103-7. PubMed ID: 1968912
[TBL] [Abstract][Full Text] [Related]
4. Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.
Kirch W; Spahn H; Köhler H; Ohnhaus EE; Mutschler E
Klin Wochenschr; 1982 Nov; 60(22):1401-7. PubMed ID: 7176462
[TBL] [Abstract][Full Text] [Related]
5. Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.
Hallengren B; Nilsson OR; Karlberg BE; Melander A; Tegler L; Wåhlin-Boll E
Eur J Clin Pharmacol; 1982; 21(5):379-84. PubMed ID: 7075643
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
Wójcicki J; Jaroszynska M; Droździk M; Pawlik A; Gawrońska-Szklarz B; Sterna R
Biopharm Drug Dispos; 2003 Jul; 24(5):211-8. PubMed ID: 12784321
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of verapamil in combination with atenolol, metoprolol and propranolol.
Warrington SJ; Holt D; Johnston A; Fitzsimons TJ
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):37S-44S. PubMed ID: 6146339
[TBL] [Abstract][Full Text] [Related]
8. Exercise and the pharmacokinetics of propranolol, verapamil and atenolol.
van Baak MA; Mooij JM; Schiffers PM
Eur J Clin Pharmacol; 1992; 43(5):547-50. PubMed ID: 1483493
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol.
Blomqvist I; Westergren G; Sandberg A; Jonsson UE; Lundborg P
Eur J Clin Pharmacol; 1988; 33 Suppl():S19-24. PubMed ID: 3371390
[TBL] [Abstract][Full Text] [Related]
10. The effect on heart rate of combining single-dose fingolimod with steady-state atenolol or diltiazem in healthy subjects.
Kovarik JM; Lu M; Riviere GJ; Barbet I; Maton S; Goldwater DR; Schmouder RL
Eur J Clin Pharmacol; 2008 May; 64(5):457-63. PubMed ID: 18196225
[TBL] [Abstract][Full Text] [Related]
11. Effects of metoprolol, alone and in combination with lidocaine, on ventricular fibrillation threshold: comparison with atenolol, propranolol, and pindolol.
Coram WM; Olson RW; Beil ME; Cabot CF; Weiss GB
J Cardiovasc Pharmacol; 1987 May; 9(5):611-21. PubMed ID: 2439844
[TBL] [Abstract][Full Text] [Related]
12. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
Kerr D; MacDonald IA; Heller SR; Tattersall RB
Br J Clin Pharmacol; 1990 Jun; 29(6):685-93. PubMed ID: 1974143
[TBL] [Abstract][Full Text] [Related]
13. [Effect of hyperlipidemia on pharmacodynamics of propranolol and atenolol].
Telatyńska-Smieszek B; Wójcicki J; Droździk M; Gawrońska-Szklarz B; Sulzyc-Bielicka V; Sterna R
Pol Arch Med Wewn; 2004 Jan; 111(1):45-51. PubMed ID: 15088420
[TBL] [Abstract][Full Text] [Related]
14. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
Gangji D; Juvent M; Niset G; Wathieu M; Degreve M; Bellens R; Poortmans J; Degre S; Fitzsimons TJ; Herchuelz A
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337
[TBL] [Abstract][Full Text] [Related]
15. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG
Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Floras JS; Jones JV; Hassan MO; Sleight P
Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
[TBL] [Abstract][Full Text] [Related]
17. Lack of a pharmacokinetic interaction between nifedipine and the beta-adrenoceptor blockers metoprolol and atenolol.
Kendall MJ; Jack DB; Laugher SJ; Lobo J; Rolf Smith S
Br J Clin Pharmacol; 1984 Sep; 18(3):331-5. PubMed ID: 6487472
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of propranolol and atenolol in patients after partial gastric resection: a comparative study.
Wójcicki J; Wojciechowski G; Wójcicki M; Kostyrka R; Sterna R; Gawronska-Szklarz B; Pawlik A; Drozdzik M; Kozlowski K
Eur J Clin Pharmacol; 2000 Apr; 56(1):75-9. PubMed ID: 10853882
[TBL] [Abstract][Full Text] [Related]
19. Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.
Perucca E; Pickles H; Richens A
Clin Pharmacol Ther; 1981 Apr; 29(4):425-33. PubMed ID: 6258838
[TBL] [Abstract][Full Text] [Related]
20. Interaction of cimetidine with metoprolol, propranolol, or atenolol.
Kirch W; Köhler H; Spahn H; Mutschler E
Lancet; 1981 Sep; 2(8245):531-2. PubMed ID: 6115283
[No Abstract] [Full Text] [Related]
[Next] [New Search]